Celldex Therapeutics Inc (CLDX) — Cash Flow-to-Debt Ratio
Celldex Therapeutics Inc (CLDX) has a Cash Flow-to-Debt Ratio of -1.19x as of March 2026, meaning its operating cash flow of $-65.59 Million could theoretically repay -1% of its total liabilities ($55.03 Million) in one year. See how much free cash does Celldex Therapeutics Inc generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Celldex Therapeutics Inc Cash Flow-to-Debt Ratio (1986–2025)
Historical debt coverage capacity for Celldex Therapeutics Inc across 39 annual periods. Also explore CLDX shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Celldex Therapeutics Inc (1986–2025)
Year-by-year debt coverage analysis for Celldex Therapeutics Inc. For market capitalisation and broader financial context, see CLDX company net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.78x | $-210.94 Million | $55.82 Million | ▼ -8.6% |
| 2024 | -3.48x | $-157.78 Million | $45.34 Million | ▼ -18.3% |
| 2023 | -2.94x | $-107.29 Million | $36.46 Million | ▲ +24.7% |
| 2022 | -3.91x | $-103.73 Million | $26.53 Million | ▼ -61.6% |
| 2021 | -2.42x | $-60.91 Million | $25.18 Million | ▼ -58.6% |
| 2020 | -1.53x | $-40.40 Million | $26.48 Million | ▲ +5.0% |
| 2019 | -1.61x | $-46.41 Million | $28.91 Million | ▲ +32.2% |
| 2018 | -2.37x | $-75.23 Million | $31.75 Million | ▼ -87.9% |
| 2017 | -1.26x | $-99.93 Million | $79.25 Million | ▼ -31.5% |
| 2016 | -0.96x | $-113.04 Million | $117.93 Million | ▲ +54.0% |
| 2015 | -2.08x | $-98.89 Million | $47.48 Million | ▲ +25.4% |
| 2014 | -2.79x | $-101.54 Million | $36.35 Million | ▼ -12.7% |
| 2013 | -2.48x | $-67.67 Million | $27.30 Million | ▼ -48.2% |
| 2012 | -1.67x | $-49.78 Million | $29.77 Million | ▼ -37.3% |
| 2011 | -1.22x | $-35.66 Million | $29.27 Million | ▼ -39.1% |
| 2010 | -0.88x | $-30.37 Million | $34.69 Million | ▼ -95.2% |
| 2009 | -0.45x | $-29.87 Million | $66.60 Million | ▼ -226.7% |
| 2008 | 0.35x | $18.28 Million | $51.66 Million | ▲ +203.9% |
| 2007 | -0.34x | $-19.30 Million | $56.69 Million | ▼ -174.8% |
| 2006 | 0.46x | $27.00 Million | $59.32 Million | ▲ +217.7% |
| 2005 | -0.39x | $-6.02 Million | $15.56 Million | ▲ +72.4% |
| 2004 | -1.40x | $-10.35 Million | $7.40 Million | ▲ +59.7% |
| 2003 | -3.47x | $-11.74 Million | $3.39 Million | ▲ +19.1% |
| 2002 | -4.28x | $-16.66 Million | $3.89 Million | ▼ -69.0% |
| 2001 | -2.53x | $-20.83 Million | $8.22 Million | ▼ -450.8% |
| 2000 | -0.46x | $-4.43 Million | $9.63 Million | ▲ +86.7% |
| 1999 | -3.46x | $-8.54 Million | $2.47 Million | ▼ -51.5% |
| 1998 | -2.28x | $-8.90 Million | $3.90 Million | ▼ -3.7% |
| 1997 | -2.20x | $-7.70 Million | $3.50 Million | ▲ +63.7% |
| 1996 | -6.06x | $-9.70 Million | $1.60 Million | ▼ -91.9% |
| 1995 | -3.16x | $-7.90 Million | $2.50 Million | ▼ -7.6% |
| 1994 | -2.94x | $-9.10 Million | $3.10 Million | ▼ -113.5% |
| 1993 | -1.38x | $-5.50 Million | $4.00 Million | ▲ +15.4% |
| 1992 | -1.63x | $-3.90 Million | $2.40 Million | ▼ -51.7% |
| 1991 | -1.07x | $-3.00 Million | $2.80 Million | ▲ +0.0% |
| 1990 | -1.07x | $-3.00 Million | $2.80 Million | ▼ -282.7% |
| 1989 | -0.28x | $-700.00K | $2.50 Million | ▼ -92.0% |
| 1988 | -0.15x | $-700.00K | $4.80 Million | ▼ -105.0% |
| 1986 | 2.93x | $12.30 Million | $4.20 Million | — |